Pituitary

Scope & Guideline

Fostering Excellence in Endocrinology Research

Introduction

Delve into the academic richness of Pituitary with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1386-341x
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1998 to 2024
AbbreviationPITUITARY / Pituitary
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Pituitary' focuses on advancing the understanding of pituitary diseases and disorders through high-quality research. Its aims encompass a wide range of topics related to pituitary function, pathologies, and treatment modalities, utilizing various methodologies including clinical studies, systematic reviews, and meta-analyses.
  1. Clinical Management of Pituitary Disorders:
    The journal emphasizes research on the clinical management of various pituitary disorders including acromegaly, Cushing's syndrome, and prolactinomas, exploring treatment efficacy and safety.
  2. Endocrine and Metabolic Research:
    A significant focus is placed on the endocrine implications of pituitary dysfunction, including hormonal therapies and their metabolic effects, with studies often examining the interaction between hormonal levels and systemic health.
  3. Surgical Techniques and Outcomes:
    Research on innovative surgical techniques, particularly endoscopic approaches for pituitary tumors, and their outcomes is a core area, aiming to improve patient safety and surgical success rates.
  4. Pathophysiology and Molecular Mechanisms:
    The journal includes studies that investigate the underlying pathophysiological mechanisms of pituitary tumors and related disorders, contributing to a better understanding of these complex conditions.
  5. Patient-Centered Outcomes and Quality of Life:
    There is a consistent focus on patient-reported outcomes and quality of life assessments, highlighting the psychosocial impact of pituitary disorders and treatments.
The journal has identified several trending and emerging themes in pituitary research, reflecting the evolving landscape of clinical practice and scientific inquiry in this field. These themes highlight areas of increasing focus and potential importance for future research.
  1. Impact of COVID-19 on Pituitary Disorders:
    Recent publications have increasingly addressed the implications of COVID-19 on patients with pituitary disorders, exploring both the direct and indirect effects of the pandemic on management and outcomes.
  2. Integration of Artificial Intelligence in Clinical Practice:
    There is a growing interest in the application of artificial intelligence and machine learning models in predicting outcomes and aiding in the clinical decision-making process for pituitary disorders.
  3. Long-term Outcomes of Hormonal Therapies:
    Emerging research is focusing on the long-term effects and outcomes of hormonal therapies, particularly in relation to acromegaly and Cushing's syndrome, reflecting a trend towards understanding the chronic implications of these treatments.
  4. Patient-Centered Research and Quality of Life:
    A notable increase in studies assessing patient-reported outcomes and quality of life following treatment for pituitary disorders indicates a shift towards more holistic approaches in managing these conditions.
  5. Research on Comorbidities Associated with Pituitary Disorders:
    There is an increasing trend in exploring the comorbid conditions associated with pituitary disorders, particularly metabolic and cardiovascular risks, emphasizing the need for comprehensive management strategies.

Declining or Waning

While the journal has a robust focus on various aspects of pituitary research, some themes appear to be declining in prominence. These waning scopes indicate shifts in research priorities or reduced interest in certain areas over recent years.
  1. Historical Perspectives on Pituitary Disorders:
    Research that focuses on historical or retrospective analyses of pituitary disorders or treatments has seen a decline, as the field shifts towards more contemporary studies with immediate clinical relevance.
  2. Basic Science and Animal Models:
    There is a noticeable decrease in studies involving basic science and animal models of pituitary disorders, as clinical applications and human studies gain more traction.
  3. Epidemiological Studies on Rare Pituitary Tumors:
    The frequency of epidemiological studies specifically targeting rare pituitary tumors has diminished, possibly due to the challenges in gathering sufficient data on these less common conditions.
  4. General Reviews on Common Pituitary Disorders:
    While systematic reviews remain important, there is less emphasis on general reviews of well-established pituitary disorders, as the focus shifts to more specific and novel research findings.

Similar Journals

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Unveiling breakthroughs in metabolism and diabetes.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Journal of the Endocrine Society

Connecting researchers and practitioners in the realm of hormones.
Publisher: ENDOCRINE SOCISSN: Frequency: 12 issues/year

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

Hormones-International Journal of Endocrinology and Metabolism

Unraveling the Complexities of Hormonal Mechanisms
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

JOURNAL OF MOLECULAR ENDOCRINOLOGY

Innovating Research at the Intersection of Hormones and Biology
Publisher: BIOSCIENTIFICA LTDISSN: 0952-5041Frequency: 6 issues/year

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

HORMONE AND METABOLIC RESEARCH

Illuminating the Science of Hormones and Metabolism
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Empowering professionals in diabetes and metabolism.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Frontiers in Endocrinology

Fostering Collaboration for Endocrine Excellence
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Cardiovascular Endocrinology & Metabolism

Connecting the Dots Between Endocrine Function and Heart Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

Hormone Molecular Biology and Clinical Investigation

Exploring the Frontiers of Hormonal Science
Publisher: WALTER DE GRUYTER GMBHISSN: 1868-1883Frequency: 12 issues/year

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

MOLECULAR AND CELLULAR ENDOCRINOLOGY

Unveiling the complexities of hormones and cellular interactions.
Publisher: ELSEVIER IRELAND LTDISSN: 0303-7207Frequency: 21 issues/year

MOLECULAR AND CELLULAR ENDOCRINOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of biochemistry, endocrinology, and molecular biology. With an ISSN of 0303-7207 and E-ISSN of 1872-8057, this esteemed journal has been disseminating significant findings since its inception in 1974 and continues to do so through 2024. Ranked in the Q1 quartile for Biochemistry and Q2 for both Endocrinology and Molecular Biology, it is recognized for its impactful contributions to research, holding impressive Scopus rankings that place it at the forefront of its category. The journal's wide-reaching influence is underscored by its commitment to quality, ensuring that only the most impactful articles advance the understanding of cellular mechanisms and hormonal regulation. Although not open-access, its relevance and rigorous peer-review process make it an essential read for researchers, professionals, and students eager to explore the complexities of endocrinology and biochemistry.